EMC INSTYTUT MEDYCZNY S.A. financials
EMC INSTYTUT MEDYCZNY S.A.
Country: PL Reporting currency: PLN Latest annual report: 2022-12-31
LEI:
2594005WSYZ0JRE8U796 Financial statements
(PLN, as reported — unscaled; 109 line items across 2 annual periods)
| Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Revenue | PLN 575.1M | PLN 514.8M |
| Raw materials & consumables used | PLN 75.4M | PLN 72.6M |
| Operating profit (EBIT) | PLN 5.4M | PLN 9.2M |
| Finance costs | PLN 5.6M | PLN 3.3M |
| Profit before tax | -PLN 243.0K | PLN 6.4M |
| Income tax expense | PLN 1.3M | PLN 2.8M |
| Profit for the year | -PLN 1.5M | PLN 3.6M |
| — attributable to owners | -PLN 1.7M | PLN 2.6M |
| — attributable to NCI | PLN 130.0K | PLN 1.0M |
| Total comprehensive income | -PLN 2.6M | PLN 3.5M |
| Cash flow statement | ||
| Net cash from operating activities | PLN 41.9M | PLN 18.9M |
| Net cash from investing activities | -PLN 28.4M | -PLN 15.2M |
| Purchase of PP&E (capex) | PLN 34.7M | PLN 27.7M |
| Net cash from financing activities | PLN 13.4M | -PLN 18.8M |
| Proceeds from borrowings | PLN 103.7M | — |
| Repayments of borrowings | PLN 79.2M | PLN 7.8M |
| Lease liability payments | PLN 8.4M | PLN 8.1M |
| Net change in cash | PLN 27.0M | -PLN 15.1M |
| Balance sheet | ||
| Total assets | PLN 431.2M | PLN 387.2M |
| Non-current assets | PLN 328.3M | PLN 311.3M |
| Property, plant & equipment | PLN 284.5M | PLN 271.6M |
| Current assets | PLN 102.9M | PLN 76.0M |
| Inventories | PLN 8.5M | PLN 8.4M |
| Trade & other receivables | PLN 54.9M | PLN 50.9M |
| Cash & equivalents | PLN 34.7M | PLN 7.8M |
| Total equity | PLN 190.7M | PLN 190.3M |
| — attributable to owners | PLN 180.5M | PLN 181.1M |
| Non-controlling interests | PLN 10.2M | PLN 9.2M |
| Non-current liabilities | PLN 117.8M | PLN 90.4M |
| Lease liabilities (non-current) | PLN 27.0M | PLN 29.1M |
| Current liabilities | PLN 122.7M | PLN 106.5M |
| Lease liabilities (current) | PLN 5.5M | PLN 7.3M |
| Trade & other payables | PLN 47.1M | PLN 39.7M |
| Deferred tax liabilities | PLN 1.0M | PLN 970.0K |
| Derived metrics | ||
| Free cash flow | PLN 7.2M | -PLN 8.8M |
| Operating margin | 0.9% | 1.8% |
| Net margin | -0.3% | 0.7% |
| Return on equity | -0.8% | 1.9% |
| Cash conversion ratio | -27.42× | 5.19× |
| Capex coverage | 1.21× | 0.68× |
| Other reported items | ||
| Accruals Classified As Noncurrent | PLN 13.1M | PLN 11.6M |
| Adjustments For Decrease Increase In Inventories | -PLN 87.0K | -PLN 17.0K |
| Adjustments For Decrease Increase In Other Operating Receivables | -PLN 4.7M | -PLN 4.6M |
| Adjustments For Depreciation and Amortisation Expense | PLN 27.1M | PLN 25.3M |
| Adjustments For Increase Decrease In Trade Account Payable | PLN 7.9M | PLN 1.2M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | -PLN 772.0K | PLN 43.0K |
| Adjustments For Provisions | PLN 3.4M | -PLN 2.8M |
| Adjustments For Reconcile Profit Loss | PLN 42.2M | PLN 12.4M |
| Adjustments For Sharebased Payments | PLN 2.1M | — |
| Adjustments For Unrealised Foreign Exchange Losses Gains | PLN 1.1M | -PLN 116.0K |
| Basic Earnings Loss Per Share From Continuing Operations | PLN -0.04 | PLN 0.12 |
| Comprehensive Income Attributable To Noncontrolling Interests | PLN 130.0K | PLN 1.0M |
| Comprehensive Income Attributable To Owners of Parent | -PLN 2.7M | PLN 2.5M |
| Contract Liabilities | PLN 2.9M | PLN 6.6M |
| Cost of Merchandise Sold | PLN 306.0K | PLN 9.0K |
| Current Accrued Expenses and Other Current Liabilities | PLN 16.8M | PLN 10.0M |
| Current Prepaid Expenses | PLN 1.5M | PLN 1.2M |
| Current Provisions For Employee Benefits | PLN 5.3M | PLN 4.1M |
| Current Tax Assets Current | PLN 158.0K | PLN 513.0K |
| Current Tax Liabilities Current | PLN 282.0K | PLN 1.5M |
| Deferred Tax Assets | PLN 5.2M | PLN 4.8M |
| Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | PLN 27.1M | PLN 25.3M |
| Diluted Earnings Loss Per Share From Continuing Operations | PLN -0.04 | PLN 0.12 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -PLN 8.0K | PLN 32.0K |
| Equity and Liabilities | PLN 431.2M | PLN 387.2M |
| Expense By Nature | PLN 577.7M | PLN 517.3M |
| Finance Income | PLN 15.0K | PLN 575.0K |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | -PLN 248.0K | -PLN 38.0K |
| Income Taxes Paid Refund Classified As Operating Activities | PLN 2.2M | PLN 4.4M |
| Increase Decrease In Cash and Cash Equivalents | PLN 27.0M | -PLN 15.1M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | PLN 900.0K | PLN 475.0K |
| Increase Decrease Through Sharebased Payment Transactions | PLN 2.1M | — |
| Increase Decrease Through Treasury Share Transactions | -PLN 9.0K | — |
| Inflows of Cash From Investing Activities | PLN 7.8M | PLN 12.5M |
| Intangible Assets Other Than Goodwill | PLN 38.0M | PLN 34.2M |
| Interest Paid Classified As Financing Activities | PLN 3.6M | PLN 2.9M |
| Interest Received Classified As Operating Activities | PLN 4.2M | PLN 2.8M |
| Investment Property | PLN 714.0K | PLN 742.0K |
| Issued Capital | PLN 165.8M | PLN 165.8M |
| Merger Reserve | -PLN 20.8M | -PLN 20.8M |
| Noncurrent Provisions For Employee Benefits | PLN 7.4M | PLN 5.7M |
| Other Adjustments To Reconcile Profit Loss | PLN 3.0K | PLN 3.0K |
| Other Cash Payments To Acquire Equity Or Debt Instruments of Other Entities Classified As Investing Activities | PLN 1.5M | — |
| Other Cash Receipts From Sales of Equity Or Debt Instruments of Other Entities Classified As Investing Activities | PLN 4.8M | PLN 12.0M |
| Other Comprehensive Income | -PLN 1.1M | -PLN 162.0K |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -PLN 1.3M | -PLN 200.0K |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -PLN 1.1M | -PLN 162.0K |
| Other Current Financial Assets | PLN 2.0K | PLN 4.8M |
| Other Current Financial Liabilities | PLN 7.2M | PLN 7.3M |
| Other Current Nonfinancial Assets | PLN 3.0M | PLN 2.3M |
| Other Current Nonfinancial Liabilities | PLN 32.5M | PLN 26.6M |
| Other Expense By Nature | PLN 8.2M | PLN 7.4M |
| Other Inflows Outflows of Cash Classified As Investing Activities | — | PLN 162.0K |
| Other Longterm Provisions | PLN 544.0K | PLN 556.0K |
| Other Noncurrent Financial Liabilities | PLN 68.7M | PLN 42.5M |
| Other Revenue | PLN 12.4M | PLN 16.9M |
| Other Shortterm Provisions | PLN 5.2M | PLN 3.4M |
| Outflows of Cash From Investing Activities | PLN 36.2M | PLN 27.7M |
| Proceeds From Issuing Shares | PLN 900.0K | — |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | PLN 3.0M | PLN 312.0K |
| Reserve of Sharebased Payments | PLN 2.1M | — |
| Retained Earnings | -PLN 62.8M | -PLN 60.1M |
| Revenue From Rendering of Services | PLN 574.9M | PLN 514.8M |
| Revenue From Sale of Goods | PLN 164.0K | PLN 14.0K |
| Services Expense | PLN 234.9M | PLN 199.2M |
| Share Premium | PLN 96.1M | PLN 96.1M |
| Social Security Contributions | PLN 34.6M | PLN 30.9M |
| Tax Expense Other Than Income Tax Expense | PLN 2.3M | PLN 1.8M |
| Wages and Salaries | PLN 194.8M | PLN 180.0M |
Methodology
Every line item above is a fact tagged in EMC INSTYTUT MEDYCZNY S.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (PLN), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.